Nifedipine

CAS 21829-25-4 13 current records 19 historicalSmall Molecule

Who holds supplier records for Nifedipine? 13 organisations hold a current record for Nifedipine: an active US FDA Type II Drug Master File or a CEP. A further 19 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), Italy (2), Spain (1), Netherlands (1) and 3 other countries (3).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Nifedipine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nifedipine

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Nifedipine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Nifedipine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (9)

Certificates of Suitability on the EDQM register for Nifedipine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
TAPI NL B.V. AmsterdamNL
CEP 1999-150 - Rev 08
Nifedipine
Aug 2026—
SULESHVARI PHARMA PRIVATE LIMITED AnkleshwarIN
CEP 2014-102 - Rev 03
Nifedipine
Jul 2026—
DIPHARMA FRANCIS S.R.L. BaranzateIT
CEP 2001-447 - Rev 03
Nifedipine
Jul 2026Inspected Mar 2025
Italy
J B CHEMICALS AND PHARMACEUTICALS LIMITED MumbaiIN
CEP 2000-096 - Rev 07
Nifedipine
Jun 2026—
SHOUGUANG FUKANG PHARMACEUTICAL CO., LTD. ShouguangCN
CEP 2022-402 - Rev 01
Nifedipine
Apr 2026—
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
CEP 2022-475 - Rev 01
Nifedipine
Apr 2026—
MOEHS IBERICA S.L. RubiES
CEP 1996-105 - Rev 06
Nifedipine
Mar 2026—
BAYER AG LeverkusenDE
R1-CEP 2000-274 - Rev 05
Nifedipine
Nov 2021—
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio MaggioreIT
R1-CEP 2009-055 - Rev 02
Nifedipine
Jul 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (19)

Organisations whose Type II DMFs for Nifedipine are no longer active. These show a past filing, not current supply.

Show all 19 historical records
  • CHINA CHEMICAL SYNTHESIS INDUSTRIAL CO LTD
    Inactive DMF 13115 · filed Aug 1998
  • Germany · Inactive DMF 11948 · filed Apr 1996
  • SUMIKA FINE CHEMICALS CO LTD
    Inactive DMF 5501, 9317 · filed Sept 1991
  • BPRL FINE CHEMICALS PRIVATE LTD
    Inactive DMF 9272 · filed Aug 1991
  • PHARMACEUTICAL WORKS POLPHARMA SA
    Inactive DMF 9162 · filed Jun 1991
  • Hungary · Inactive DMF 8794 · filed Oct 1990
  • NORDIC SYNTHESIS AB
    Inactive DMF 8043 · filed Apr 1989
  • CADILA LABORATORIES PVT LTD
    Inactive DMF 7934 · filed Feb 1989
  • IROPHARM LTD
    Inactive DMF 7563 · filed Jul 1988
  • Canada · Inactive DMF 7245 · filed Dec 1987
  • PFC ITALIANA SRL DIV ALFA CHEMICALS ITALIANA
    Inactive DMF 6860 · filed Feb 1987
  • SELOC FRANCE
    Inactive DMF 6772 · filed Jan 1987
  • FARMOS GROUP LTD MEDIPOLAR
    Inactive DMF 6303 · filed Apr 1986
  • SIEGFRIED AG
    Inactive DMF 6246 · filed Mar 1986
  • LEK PHARMACEUTICAL AND CHEMICAL CO DD
    Inactive DMF 6335 · filed Mar 1986
  • INTERMEDI CHIMICI SINTETICI SPA ZONA INDUSTRIALE
    Inactive DMF 6321 · filed Feb 1986
  • India · Inactive DMF 5881 · filed Jun 1985
  • KRKA PHARMACEUTICAL AND CHEMICAL WORKS
    Inactive DMF 5295 · filed Mar 1984
  • BAYER HEALTHCARE AG
    Inactive DMF 3672 · filed Dec 1979

Overview

Nifedipine is a calcium channel blocker used primarily in the management of systemic and pulmonary hypertension. It works by inhibiting the influx of calcium ions into vascular and cardiac smooth muscle, thus reducing vascular resistance and myocardial contractility.

Chemical identity

IUPAC name
dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Canonical SMILES
CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
InChIKey
HYIMSNHJOBLJNT-UHFFFAOYSA-N
Synonyms
Procardia API, adalat, afeditab cr, bay a 1040, bay-a-1040, coracten, nifedipine slow release, nifedipinum, nsc-757242, procardia

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Dihydropyridine Calcium Channel Blocker
Mechanism of action
Calcium Channel Antagonists
Chemical structure
Dihydropyridines

Therapeutic areas

CardiovascularHypertensionAngina

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Nifedipine?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Nifedipine: Dipharma Francis Srl (Italy), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), MOEHS IBERICA SL (Spain), SHILPA PHARMA LIFESCIENCES LTD (India), TAPI NL BV (Netherlands), EIRCHEM PHARMA SERVICES LTD (Ireland), SHARON BIO MEDICINE LTD (India) and Unichem Laboratories Ltd. (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Nifedipine Drug Master Files are active?

Dipharma Francis Srl (DMF 6505), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 6339), MOEHS IBERICA SL (DMF 7504), SHILPA PHARMA LIFESCIENCES LTD (DMF 36235), TAPI NL BV (DMF 6197), EIRCHEM PHARMA SERVICES LTD (DMF 29497), SHARON BIO MEDICINE LTD (DMF 25557) and Unichem Laboratories Ltd. (DMF 33562) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Nifedipine records mean?

19 organisations have only inactive Type II DMFs for Nifedipine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Nifedipine have a European Certificate of Suitability?

Yes. 9 organisations hold a valid CEP for Nifedipine on the EDQM register, including TAPI NL B.V. Amsterdam (NL), SULESHVARI PHARMA PRIVATE LIMITED Ankleshwar (IN), DIPHARMA FRANCIS S.R.L. Baranzate (IT), J B CHEMICALS AND PHARMACEUTICALS LIMITED Mumbai (IN), SHOUGUANG FUKANG PHARMACEUTICAL CO., LTD. Shouguang (CN) and SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Nifedipine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Nifedipine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.